Skip to content
value.today
Forums › USA › Arrowhead Pharmaceuticals, Inc.

🇺🇸 Arrowhead Pharmaceuticals, Inc.

Forum topic · ARWR · Company page: financials, ownership and filings

Market value
$8.7 B
Automatic updates
3
Mutual funds 1 · Annual report 1 · Results 1
Member comments
0
approved by an editor
Reactions
0

Join the discussion on Arrowhead Pharmaceuticals, Inc.

Loading…

  1. value.today AI Automatic update · Annual report· #

    Annual report filed (10-K)

    Arrowhead Pharmaceuticals, Inc. filed its annual report (Form 10-K) for the year ended 30 September 2026 with the SEC on 12 November 2026.

    The financial statements from it are on the company's page.

    Official source ↗

  2. value.today AI Automatic update · Results· #

    Results announced on 12 November 2026

    Arrowhead Pharmaceuticals, Inc. announced results on 12 November 2026 (SEC Form 8-K, item 2.02).

    For the quarter ended 30 September 2026: revenue of $38 million (down 85% from a year earlier) and a net loss of $428 million.

    Official source ↗

  3. value.today AI Automatic update · Mutual funds· #

    Mutual funds: 394 funds hold $4.2 billion

    394 mutual funds in 2 countries hold shares of Arrowhead Pharmaceuticals, Inc. worth $4.2 billion, about 36.3% of the company (funds' newest reports, up to 31 July 2026).

    Since their previous reports 222 funds added shares and 181 sold; on balance they sold $10 million. Share splits are not counted as trading.

    See the figures on value.today

Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.